| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.0042 | 1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |